Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-15-017860)

Filing Details

Accession Number:: 0001127602-15-017860
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-19 16:53:03
Reporting Period:: 2015-05-18

Filing Date:: 2015-05-19
Accepted Time:: 2015-05-19 16:53:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882796	Biocryst Pharmaceuticals Inc	BCRX	Biological Products, (No Disgnostic Substances) (2836)	621413174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1230708	Ii R Thomas Staab	4505 Emperor Blvd. Suite 200 Durham NC 27703	Senior Vice President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-18	3,000	$11.00	162,144	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2015.